Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;39(2):153-163.
doi: 10.7518/hxkq.2021.02.005.

[Sitagliptin inhibits lipopolysaccharide-induced inflammatory response in human gingival fibroblasts by blocking nuclear factor-κB signaling pathway]

[Article in Chinese]
Affiliations

[Sitagliptin inhibits lipopolysaccharide-induced inflammatory response in human gingival fibroblasts by blocking nuclear factor-κB signaling pathway]

[Article in Chinese]
Xiang Liu et al. Hua Xi Kou Qiang Yi Xue Za Zhi. .

Abstract

Objectives: This study was performed to clarify the effects of sitagliptin on Porphyromonas gingivalis-lipopolysaccharide (LPS)-induced inflammatory response in human gingival fibroblasts (HGFs), explore the molecular mechanism of its roles, and provide a foundation for clinical therapeutics in periodontitis.

Methods: Healthy gingival samples were collected from the donors. HGFs were isolated with enzymic digestion method and identified. The effects of LPS and sitagliptin on cell viability were detected by cell-counting kit-8 (CCK8). The mRNA levels of inflammatory cytokines, namely, interleukin (IL)-6, IL-8, C-C motif ligand 2 (CCL2), and superoxide dismutase 2 (SOD2), were evaluated by quantity real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immune sorbent assay (ELISA) was used to measure the secretion protein levels of IL-6, IL-8, and CCL2. Western blot analysis was used to further investigate the activation of nuclear factor (NF)-κB signaling pathway. The effect of NF-κB pathway inhibitor BAY11-7082 on LPS-induced HGF inflammatory cytokines at the gene level was verified by qRT-PCR.

Results: Low concentrations of sitagliptin (0.1, 0.25, and 0.5 µmol·L-1) did not affect HGF growth in 24 and 48 h, whereas high concentrations of sitagliptin (5-1 000 µmol·L-1) significantly inhibited cell proliferation. Sitagliptin suppressed 5 µg·mL-1 of LPS-induced IL-6, IL-8, CCL2, and SOD2 gene expression levels in HGF in a concentration-dependent manner. Furthermore, sitagliptin significantly decreased the elevated secretion of IL-6, IL-8, and CCL2 protein induced by LPS. Western blot analysis showed that 0.5 µmol·L-1 of sitagliptin significantly inhibited LPS-induced NF-κB signaling pathway activation. Results of qRT-PCR analysis indicated that 0.5 µmol·L-1 of sitagliptin and 5 µmol·L-1 of BAY11-7082 significantly inhibited LPS-induced IL-6, IL-8, CCL2, and SOD2 gene expressions.

Conclusions: Sitagliptin could significantly inhibit LPS-induced HGF inflammatory response by blocking the NF-κB signaling pathway activation.

目的: 明确西格列汀对牙龈卟啉单胞菌脂多糖(LPS)诱导的人牙龈成纤维细胞(HGF)炎症反应的影响,并探讨其发挥作用的分子学机制,为未来西格列汀在牙周炎治疗中的应用提供初步的实验依据。方法: 收集临床患者健康牙龈组织标本,利用酶消化法分离培养HGF并进行细胞来源鉴定;采用细胞增殖-毒性检测试剂盒检测LPS和西格列汀与HGF共培养24、48 h细胞增殖变化;通过实时荧光定量聚合酶链式反应(qRT-PCR)检测炎性细胞因子白细胞介素(IL)-6、IL-8、趋化因子配体2(CCL2)、超氧化物歧化酶2(SOD2)的基因表达水平;酶联免疫吸附实验检测细胞培养上清液中IL-6、IL-8和CCL2的蛋白表达水平;应用蛋白免疫印迹法检测核因子-κB(NF-κB)信号通路的激活情况,通过qRT-PCR验证NF-κB通路抑制剂BAY11-7082对LPS诱导的HGF炎症细胞因子基因表达水平的影响。结果: 低浓度的西格列汀(0.1、0.25、0.5 µmol·L-1)作用24、48 h对HGF的生长无影响,而高浓度西格列汀(5~1 000 µmol·L-1)明显抑制了细胞增殖。西格列汀浓度依赖性抑制5 µg·mL-1 LPS诱导的HGF中IL-6、IL-8、CCL2和SOD2的基因表达水平。此外,西格列汀显著抑制LPS诱导的IL-6、IL-8和CCL2蛋白表达水平。蛋白免疫印迹结果表明:0.5 µmol·L-1西格列汀显著性抑制了LPS诱导的NF-κB信号通路激活,qRT-PCR结果表明0.5 µmol·L-1西格列汀与5 µmol·L-1BAY11-7082均显著抑制了LPS诱导的IL-6、IL-8、CCL2和SOD2的基因表达水平。结论: 西格列汀通过阻断NF-κB信号通路的激活来抑制LPS诱导的HGF炎症反应。.

Keywords: Sitagliptin; human gingival fibroblasts; inflammation; lipopolysaccharide; nuclear factor-κB.

PubMed Disclaimer

Conflict of interest statement

利益冲突声明:作者声明本文无利益冲突。

Figures

图 1
图 1. 分离和培养HGF
Fig 1 Isolation and culture of HGFs A:原代培养HGF × 40;B:第4代HGF × 40;C:第4代HGF × 100。
图 2
图 2. HGF的鉴定 荧光显微镜 × 400
Fig 2 Identification of HGFs fluorescence microscope × 400 上:波形丝蛋白染色阳性;下:角蛋白17染色阴性;左:DAPI;中上:波形丝蛋白;中下:角蛋白;右:图层合并。
图 3
图 3. 不同浓度西格列汀对HGF活性的影响
Fig 3 Effects of sitagliptin at different concentrations on HGFs viability A:24 h;B:48 h。与对照组相比,***P<0.001,****P<0.000; ns: 差异无统计学意义。
图 4
图 4. 不同浓度西格列汀和5 µg·mL−1 LPS共同作用对HGF活性的影响
Fig 4 Effects of sitagliptin at different concentrations and 5 µg·mL−1 LPS on the viability of HGFs A:24 h;B:48 h。
图 5
图 5. 西格列汀对LPS诱导的HGF炎症细胞因子mRNA表达水平的影响
Fig 5 Effects of sitagliptin on the mRNA expression levels of LPS-induced HGFs inflammatory cytokines A:CCL2 mRNA表达水平;B:IL-6 mRNA表达水平;C:IL-8 mRNA表达水平;D:SOD2 mRNA表达水平。与对照组相比,####P<0.000 1;与LPS组相比,*P<0.05,**P<0.01,***P<0.001,****P<0.000 1; ns:差异无统计学意义。
图 6
图 6. 西格列汀对LPS诱导的HGF炎症细胞因子蛋白表达水平的影响
Fig 6 Effects of sitagliptin on the protein expression levels of LPS-induced HGFs inflammatory cytokines A:CCL2蛋白表达水平;B:IL-6蛋白表达水平;C:IL-8蛋白表达水平。与对照组相比,##P<0.01,####P<0.000 1;与LPS组相比,*P<0.05,**P<0.01,***P<0.001,****P<0.000 1;ns: 差异无统计学意义。
图 7
图 7. 西格列汀和BAY11-7082对LPS诱导的NF-κB通路活化的影响
Fig 7 Effects of sitagliptin and BAY11-7082 on LPS-induced activation of NF-κB pathway A:西格列汀和BAY11-7082对HGF中p-p65蛋白的表达影响及灰度分析p-p65/p65相对表达量;B:西格列汀和BAY11-7082对HGF中IκBα和p-IκBα蛋白的表达影响及灰度分析IκBα/GAPDH和p-IκBα/IκBα相对表达量。与对照组相比,####P<0.000 1;与LPS组相比,***P<0.001,****P<0.000 1。
图 8
图 8. 西格列汀和BAY11-7082对LPS诱导的炎症因子表达的影响
Fig 8 Effects of sitagliptin and BAY11-7082 on LPS-induced inflammatory cytokines A:CCL2 mRNA表达水平;B:IL-6 mRNA表达水平;C:IL-8 mRNA表达水平;D:SOD2 mRNA表达水平。与对照组相比,####P<0.000 1;与LPS组相比,***P<0.001,****P<0.000 1。
图 9
图 9. 西格列汀在LPS诱导的NF-κB信号通路中的作用机制
Fig 9 Putative mechanism for the role of sitagliptin in LPS-induced NF-κB signaling pathway

Similar articles

Cited by

References

    1. Ji S, Choi YS, Choi Y. Bacterial invasion and persistence: critical events in the pathogenesis of periodontitis[J] J Periodontal Res. 2015;50(5):570–585. - PubMed
    1. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction[J] Periodontol 2000. 2007;43:160–232. - PubMed
    1. Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis[J] Periodontol 2000. 2015;69(1):7–17. - PubMed
    1. Laine ML, Crielaard W, Loos BG. Genetic susceptibility to periodontitis[J] Periodontol 2000. 2012;58(1):37–68. - PubMed
    1. Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen[J] FEMS Microbiol Lett. 2012;333(1):1–9. - PubMed

LinkOut - more resources